Trevi Therapeutics (TRVI) Assets Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.85% |
| Dec 31, 2025 | 74.43% |
| Sep 30, 2025 | 189.31% |
| Jun 30, 2025 | 182.26% |
| Mar 31, 2025 | 36.21% |
| Dec 31, 2024 | 24.05% |
| Sep 30, 2024 | -28.14% |
| Jun 30, 2024 | -26.90% |
| Mar 31, 2024 | -32.40% |
| Dec 31, 2023 | -27.32% |
| Sep 30, 2023 | -25.29% |
| Jun 30, 2023 | 24.03% |
| Mar 31, 2023 | 282.43% |
| Dec 31, 2022 | 219.73% |
| Sep 30, 2022 | 306.26% |
| Jun 30, 2022 | 107.96% |
| Mar 31, 2022 | -29.11% |
| Dec 31, 2021 | -18.37% |
| Sep 30, 2021 | -43.46% |
| Jun 30, 2021 | -16.72% |
| Mar 31, 2021 | -20.97% |
| Dec 31, 2020 | -21.45% |
| Sep 30, 2020 | -15.36% |
| Jun 30, 2020 | -37.42% |
| Mar 31, 2020 | 215.61% |
| Dec 31, 2019 | 470.03% |